These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. CD133 initiates tumors, induces epithelial-mesenchymal transition and increases metastasis in pancreatic cancer. Nomura A; Banerjee S; Chugh R; Dudeja V; Yamamoto M; Vickers SM; Saluja AK Oncotarget; 2015 Apr; 6(10):8313-22. PubMed ID: 25829252 [TBL] [Abstract][Full Text] [Related]
3. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway. Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247 [TBL] [Abstract][Full Text] [Related]
4. CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to Minnelide. Banerjee S; Nomura A; Sangwan V; Chugh R; Dudeja V; Vickers SM; Saluja A Clin Cancer Res; 2014 May; 20(9):2388-99. PubMed ID: 24634377 [TBL] [Abstract][Full Text] [Related]
5. Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells. Wang D; Xiang T; Zhao Z; Lin K; Yin P; Jiang L; Liang Z; Zhu B Oncotarget; 2016 Nov; 7(46):76006-76020. PubMed ID: 27738346 [TBL] [Abstract][Full Text] [Related]
6. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling. Tang KH; Ma S; Lee TK; Chan YP; Kwan PS; Tong CM; Ng IO; Man K; To KF; Lai PB; Lo CM; Guan XY; Chan KW Hepatology; 2012 Mar; 55(3):807-20. PubMed ID: 21994122 [TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway. Lai FB; Liu WT; Jing YY; Yu GF; Han ZP; Yang X; Zeng JX; Zhang HJ; Shi RY; Li XY; Pan XR; Li R; Zhao QD; Wu MC; Zhang P; Liu JF; Wei LX Cancer Lett; 2016 Aug; 378(2):131-41. PubMed ID: 27208741 [TBL] [Abstract][Full Text] [Related]
8. Asporin promotes pancreatic cancer cell invasion and migration by regulating the epithelial-to-mesenchymal transition (EMT) through both autocrine and paracrine mechanisms. Wang L; Wu H; Wang L; Zhang H; Lu J; Liang Z; Liu T Cancer Lett; 2017 Jul; 398():24-36. PubMed ID: 28400334 [TBL] [Abstract][Full Text] [Related]
9. Targeting Notch1 and IKKα Enhanced NF-κB Activation in CD133 Quan XX; Hawk NV; Chen W; Coupar J; Lee SK; Petersen DW; Meltzer PS; Montemarano A; Braun M; Chen Z; Van Waes C Mol Cancer Ther; 2018 Sep; 17(9):2034-2048. PubMed ID: 29959199 [TBL] [Abstract][Full Text] [Related]
10. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer. Zhang Y; Wei J; Wang H; Xue X; An Y; Tang D; Yuan Z; Wang F; Wu J; Zhang J; Miao Y Oncol Rep; 2012 May; 27(5):1599-605. PubMed ID: 22322379 [TBL] [Abstract][Full Text] [Related]
11. CD133 facilitates epithelial-mesenchymal transition through interaction with the ERK pathway in pancreatic cancer metastasis. Ding Q; Miyazaki Y; Tsukasa K; Matsubara S; Yoshimitsu M; Takao S Mol Cancer; 2014 Jan; 13():15. PubMed ID: 24468059 [TBL] [Abstract][Full Text] [Related]
12. Autocrine CCL5 signaling promotes invasion and migration of CD133+ ovarian cancer stem-like cells via NF-κB-mediated MMP-9 upregulation. Long H; Xie R; Xiang T; Zhao Z; Lin S; Liang Z; Chen Z; Zhu B Stem Cells; 2012 Oct; 30(10):2309-19. PubMed ID: 22887854 [TBL] [Abstract][Full Text] [Related]
13. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells. Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041 [TBL] [Abstract][Full Text] [Related]
14. Effect of Bmi-1-mediated NF-κB signaling pathway on the stem-like properties of CD133+ human liver cancer cells. Ma DQ; Zhang YH; Ding DP; Li J; Chen LL; Tian YY; Ao KJ Cancer Biomark; 2018; 22(3):575-585. PubMed ID: 29843222 [TBL] [Abstract][Full Text] [Related]
15. Polycomb complex protein BMI-1 promotes invasion and metastasis of pancreatic cancer stem cells by activating PI3K/AKT signaling, an ex vivo, in vitro, and in vivo study. Wang MC; Jiao M; Wu T; Jing L; Cui J; Guo H; Tian T; Ruan ZP; Wei YC; Jiang LL; Sun HF; Huang LX; Nan KJ; Li CL Oncotarget; 2016 Feb; 7(8):9586-99. PubMed ID: 26840020 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of NF-kappa B pathway leads to deregulation of epithelial-mesenchymal transition and neural invasion in pancreatic cancer. Nomura A; Majumder K; Giri B; Dauer P; Dudeja V; Roy S; Banerjee S; Saluja AK Lab Invest; 2016 Dec; 96(12):1268-1278. PubMed ID: 27775688 [TBL] [Abstract][Full Text] [Related]
17. Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity. Gupta VK; Sharma NS; Kesh K; Dauer P; Nomura A; Giri B; Dudeja V; Banerjee S; Bhattacharya S; Saluja A; Banerjee S Cancer Lett; 2018 Dec; 439():101-112. PubMed ID: 30290209 [TBL] [Abstract][Full Text] [Related]
18. CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer. Tu Z; Xie S; Xiong M; Liu Y; Yang X; Tembo KM; Huang J; Hu W; Huang X; Pan S; Liu P; Altaf E; Kang G; Xiong J; Zhang Q Int J Oncol; 2017 Feb; 50(2):505-514. PubMed ID: 28000861 [TBL] [Abstract][Full Text] [Related]
20. Artemin regulates CXCR4 expression to induce migration and invasion in pancreatic cancer cells through activation of NF-κB signaling. Wang J; Wang H; Cai J; Du S; Xin B; Wei W; Zhang T; Shen X Exp Cell Res; 2018 Apr; 365(1):12-23. PubMed ID: 29453972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]